Investment Firm Novo Names Moelis’s Kutay as New Chief Executive
- Kutay starts in his new role in September based in Copenhagen
- Novo manages more than 350 billion kroner in foundation assets
This article is for subscribers only.
Novo A/S, the investment fund that holds stakes in health-care companies including Novo Nordisk A/S and Novozymes A/S, has hired Kasim Kutay from financial adviser Moelis & Co. to be its new chief executive officer.
Kutay, 51, will start in the role on Sept. 1 and will move to Copenhagen, Novo said in a statement Tuesday. He’s departing from Moelis, where he’s co-head of Europe and a member of the investment bank’s management committee.